NDC 50090-0140-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0140
- Requested NDC
- 50090-0140-01
- Package NDCs from labels
- 50090-0140-0, 50090-0140-1, 50090-0140-8, 50090-0140-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-0140-0 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-1 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-8 | 2023-08-25 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-0 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-1 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 50090-0140-8 | 2023-01-30 | Hydrochlorothiazide Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0140-0 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 17 | |
| 50090-0140-1 | Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 17 | |
| 50090-0140-8 | Hydrochlorothiazide | 200 in 1 BOTTLE | TABLET | 200 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0140 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS] | 13 | Current NDC, Legacy NDC, 3 package rows | 20230920_96838fd0-ad87-4b45-b2c0-efdd1d2f3d1e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0140-0 | EA - Each | 50090-0140 | 5111d83c-f615-4fe4-b7a9-88553dc7d77f | 1 | 2021-05-05 |
| 50090-0140-1 | EA - Each | 50090-0140 | 54f7a2d5-3b27-4528-a957-7fb7f78a660a | 1 | 2021-05-05 |
| 50090-0140-8 | EA - Each | 50090-0140 | 2bb61eb3-a0bf-4ba4-afbe-f05dd027d9bc | 1 | 2023-10-16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 446e6998-01f6-4de0-be57-7fecf5448e95 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | b9ee689a-ea12-435d-b01c-70d45891e62f | 2026-08-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-08-06 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| ROROBELL WAWA Whitening Tooth | SILICA, HYDROGEN PEROXIDE, TOCOPHERYL ACETATE | ROROBELL | 58336a0d-49dd-ef13-e063-6394a90a38c1 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| Silicea 6X | SILICON DIOXIDE | Hyland's Inc. | db4be3c1-aa7e-24a2-e053-2a95a90a0c66 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 43a4d6dd-bcca-412c-b051-ed470208ddb6 | 2026-08-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Viona Pharmaceuticals Inc | 57505d73-f2a8-430b-8703-a0a6bb733c7d | 2026-07-31 | Warnings, Adverse reactions | 0J48LPH2TH |
| Smogstat | ECHINACEA (ANGUSTIFOLIA), HYPERICUM PERFORATUM, HYDRASTIS CANADENSIS, SYMPHYTUM OFFICINALE, ARSENICUM ALBUM, CARBO VEGETABILIS, CAUSTICUM, KALI CARBONICUM, NATRUM SULPHURICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA | Energique, Inc. | 59f63e2b-24fa-43a0-8334-02e6729c6ac1 | 2026-07-31 | Warnings | ETJ7Z6XBU4 |
| Muscle Ice | PHYTOLACCA DECANDRA, BELLIS PERENNIS, LEDUM PALUSTRE, RUTA GRAVEOLENS, SYMPHYTUM OFFICINALE, MAGNESIA PHOSPHORICA, SILICEA, MENTHOL (CRYSTALS) | Peaceful Mountain, Inc. | 03b6e2a9-f335-4ae2-9011-80bd019afb72 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 167f49f0-2d39-49a2-9f9e-1359a7c7ba3d | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, INC. | 17362ff8-07bb-42c6-a100-8adb93be0348 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9f9cd7a7-be95-4ea8-8247-eb7ecbd36936 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 0789baef-3424-43ab-a3fb-4908172da565 | 2026-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Redpharm Drug | 57436cfa-9b94-89bf-e063-6394a90aa264 | 2026-07-23 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 574d2679-c036-fa12-e063-6394a90aef33 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | d7214539-6c3d-466a-a474-6fde096fa182 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Prid | ICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFUR | Hyland's Inc. | 49689eeb-7790-07f1-e063-6294a90a2df2 | 2026-07-16 | Warnings | ETJ7Z6XBU4 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 03b7e52e-0003-47c3-af12-93ef00800b37 | 2026-07-16 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | ee1eaaf6-050b-48af-942b-5e3451edc164 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.